REGULATED PRESS RELEASE

from MEDESIS PHARMA (EPA:ALMDP)

MEDESIS PHARMA to participate to the World Congress for Clinical Trials in Alzheimer’s Disease, in Madrid at the end of October 2024 (CTAD, Clinical Trials Alzheimer’s Disease)

See all MEDESIS PHARMA news